DOI: 10.4244/EIJV8SQA1

Welcome to PCR London Valves 2012

Martyn Thomas1, MD, PhD; Stephan Windecker2, MD

Welcome to this dedicated EuroIntervention Supplement which accompanies PCR London Valves 2012. It has been an exciting year for London because of the Olympic Games, and in this third year of PCR London Valves we have moved to a new venue, The Queen Elizabeth Conference Centre, just opposite Westminster Abbey near the Houses of Parliament and “Big Ben”. This was a very positive move prompted by the need for more capacity due to the growing number of participants participating in the course.

PCR London Valves has now become an official meeting of EAPCI and the PCR family, which anchors the meeting within the well established European culture of invasive cardiology with a major focus on education. Contributions to the course, and to this journal as well, have come from all over the world, and we believe the course is now the global leader in interventional therapies for valvular heart disease.

We are confident that this EuroIntervention Supplement reflects this position and provides a collage of the meeting. In order to introduce complex technologies into daily practice it is essential that high quality and consistent data is collected as any new procedure is introduced into clinical practice. There is no doubt that the interventional community has “stepped up to the plate” in terms of robust data collection over the last three to four years. Pivotal in this process has been the establishment of the VARC clinical endpoint initiative which is now universally used in the development and reporting of valvular heart disease trials. Other examples are the recent publication of the collective TAVI experience in France in the New England Journal of Medicine as well as the launch of the TCVT initiative of the ESC under the leadership of Carlo Di Mario. These initiatives are reflected in the important accompanying editorials by Jean Fajadet and Patrick Serruys.

This year will be the 10th anniversary of the first transcatheter aortic valve implantation (TAVI) performed by Alain Cribier in 2002. We are delighted that Alain has contributed a manuscript to this Supplement to commemorate this milestone. We do also recognise that the first ever transcatheter valve intervention was done by Phillip Bonhoeffer in the year 2000 with an intervention to the pulmonary valve.

The spirit of PCR London Valves 2012 will be a practical interactive meeting of “Heart Teams” who are dedicated to sharing experiences which will lead to ever improved outcomes for patients with valvular heart disease. A large section of the meeting will be dedicated to live case and taped demonstrations. There will, however, be a number of important didactic sessions within which the most important topics of transcatheter valvular interventions will be discussed. A representation of these sessions in manuscript form is contained in this Supplement. We are extremely grateful to the authors who have helped to put together this Supplement, which reflects “state of the art” thinking in valvular heart intervention.

The important topics covered in this Supplement include TAVI and residual aortic regurgitation, TAVI complicated by stroke, the incidence and treatment of paravalvular leaks, transcatheter mitral interventions, new transcatheter valvular technologies and emerging innovations.

In addition, abstract submissions were a feature of this year’s meeting for the first time. We are delighted to publish the accepted abstracts in this Supplement. The top scoring abstract for the meeting was entitled “Transcatheter mitral valve-in-valve/valve in ring implantations for degenerative post-surgical valves: results from the global valve-in-valve registry” by Dvir and colleagues and this abstract is featured on page Q119 of the Supplement.

We hope you enjoy reading this Supplement. For those of you lucky enough to be in London in October, welcome, and enjoy one of the greatest cities in the world and the largest, most practical and interactive transcatheter valve meeting. Please feel free to share your experience both during the meeting, after reading the Supplement and in the future, to ensure we can all deliver optimal care to our patients.

Volume 8 Supplement Q
Sep 30, 2012
Volume 8 Supplement Q
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-23-00052 Mar 18, 2024
Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation
Joner M and Wild L
free

Debate

10.4244/EIJ-E-24-00005 Mar 18, 2024
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
McEntegart M et al
free

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al

Original Research

10.4244/EIJ-D-23-00783 Mar 18, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
Meier D et al
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved